title: Artemether-Lumefantrine Treatment Failure in Nonimmune European Travelers With Plasmodium falciparum Malaria: Do We Need to Reconsider Dosing in Patients From Nonendemic Regions?
authors.affiliation: Swiss Tropical and Public Health Institute, Basel.|University of Basel; and.
authors.forename: Andreas
authors.initials: A
authors.lastname: Neumayr
authors.affiliation: Swiss Tropical and Public Health Institute, Basel.|University of Basel; and.
authors.forename: Daniel Henry
authors.initials: DH
authors.lastname: Paris
authors.affiliation: University of Basel; and.|Infectious Disease Service and Department of Ambulatory Care, University Hospital, Lausanne, Switzerland.
authors.forename: Blaise
authors.initials: B
authors.lastname: Genton
authors.affiliation: Swiss Tropical and Public Health Institute, Basel.|University of Basel; and.
authors.forename: Christoph
authors.initials: C
authors.lastname: Hatz
mesh_terms: D000077549:Artemether; D006801:Humans; D000078102:Lumefantrine; D016778:Malaria, Falciparum; D012189:Retrospective Studies; D013548:Sweden; D017211:Treatment Failure
chemical_list: D000077549:Artemether; D000078102:Lumefantrine